Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J2357 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11Office |
| Hospital Outpatient Group (APC) | APC 9300 - Omalizumab injection |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 06360250 |
| Medicare Fee Schedule | $45.69 per 5 mg (October 2026 ASP)View Medicare rates for J2357 |
| Medicaid Fee Schedule | $45.265 median of the 8 states in the free previewView Medicaid rates for J2357 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 50242004062 - XOLAIR (omalizumab) 202.5 mg/1.4mL, injection, solution • 50242004086 - XOLAIR (omalizumab) 202.5 mg/1.4mL, injection, solution • 50242021401 - Xolair PFS (omalizumab) 75 mg/.5mL, injection, solution • 50242021403 - XOLAIR PFS 75 MG/0.5 ML • 50242021455 - XOLAIR AUTOINJECTOR (PF) 75 MG/0.5 ML |
National average reimbursement for HCPCS J2357 by major payers:

$42.65
BCBS / Anthem

$39.60
UnitedHealthcare

$43.85
Aetna

$40.73
Cigna
Choose a payer to see a sample of rates for HCPCS J2357.
Seher Anjum
Shannon Clinic
Netochukwu Okafor
Prisma Health-University Medical Group
Oliver Harden
Ch Specialty Services Sc LLC / Dana L Wiley Md PA
Kenneth Yang
Texas Digestive Disease Consultants
Tolulola Adeola
Physicians Eldercare PA
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J2357 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J2357. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 50242004062-NDC | XOLAIR (omalizumab) 202.5 mg/1.4mL, injection, solution |
| 50242004086-NDC | XOLAIR (omalizumab) 202.5 mg/1.4mL, injection, solution |
| 50242021401-NDC | Xolair PFS (omalizumab) 75 mg/.5mL, injection, solution |
| J2357-HCPCS | Injection, omalizumab, 5 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J2357. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J2357 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J2357) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J2357 to APC 9300 (Omalizumab injection). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J2357 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J2357 under these revenue codes: 0636 and 0250. A revenue code names the hospital department or charge category for the line; it does not change what the service is.